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Abstract Structural studies of a-fetoprotein (AFP) from human 
cord serum have shown that a decrease in pH to 3.1 leads to a 
considerable conformational rearrangement of the protein mole- 
cule. The acid form of AFP belongs to the class of denatured 
conformations and fulfills all the requirements of the molten glob- 
ule state. The possible functional role of such a transformation 
is discussed. 
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In the present paper we show that the acid form of human 
AFP is denatured (i.e. it lacks a rigid tertiary structure), but is 
practically as compact as the native protein molecule and has 
a native-like content of secondary structure. Its affinity to the 
hydrophobic fluorescent probe (ANS) is much higher than that 
observed for the native or completely unfolded states of AFE  
All this means that at low pH the AFP  molecule is transformed 
into the molten globule state. We suggest hat this observation 
can be of functional significance. 
2. Materials and methods 
I. Introduction 
~-Fetoprotein (AFP) is a glycoprotein which consists o f -600  
amino acid residues. This protein is present at a high concentra- 
tion in embryonal and fetal sera, while only traces of AFP  are 
detected in adult sera. On the other hand, it has been shown 
that a considerable increase in AFP  content in adults reflects 
the development of pathological conditions [1], such as hepato- 
cellular carcinoma or germ cell teratocarcinoma. It has been 
established that AFP  possesses a lot of biological activity - it 
participates in the transport of various hydrophobic ligands 
such as unsaturated fatty acids [2] and estrogens [3,4], it takes 
part in cell multiplication [5], it can affect cell metabolism [6] 
and interact with T-lymphocytes [7,8] and macrophages [9,10], 
it binds bilirubin as well as Ni 2+ and Cu 2+ ions, and, finally, it 
possesses immunosuppressive properties [9,11]. The biochemi- 
cal and structural properties of AFP  and its numerous biolog- 
ical functions have been reviewed [1,12-14]. 
The molten globule (see [15 19] for reviews) is the third 
thermodynamic state of the protein molecule [20-22] which 
exists as an equilibrium intermediate of many proteins under 
mild denaturing conditions. It accumulates as a universal ki- 
netic intermediate during protein folding. The protein molecule 
in the molten globule state is almost as compact as in the native 
state, has a pronounced secondary structure, and differs from 
the native molecule mainly by the absence of tight packing of 
side chains in the protein core and by a substantial increase in 
fluctuations [15 19]. It has been suggested [23] and confirmed 
experimentally [24-27] that the molten globule state of a protein 
molecule can be of large physiological importance (see [28] for 
review). 
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2.1. MateriaLs" 
AFP was isolated from human cord serum with the use of metal- 
chelate and reverse-phase chromatography. The procedure of protein 
isolation and purification will be described elsewhere. 
The method of immunorocketry electrophoresis was used for the 
identification of chromatographic fractions containing AFP. The pro- 
tein purity was checked by HPLC reverse-phase chromatography, SDS 
and native polyacrylamide gel electrophoresis (PAGE) with im- 
munoblotting, and by the ELISA test with antibodies against human 
serum albumin, c~-antitrypsin a d transferrin. The protein purity was 
no less than 98% according to all these tests. 
Electrophoresis reagents were from Bio-Rad. Buffer compounds 
were analytical or extra pure grade and were used without additional 
purification. Desirable pH values were adjusted by the addition of 
0.5-1.0 N HCI or NaCI. All solutions were prepared on bi-distilled 
water and contained 0.15 M NaCI. 
2.2. Experimental proeedures 
Calorimetric measurements were carried out by a precision scanning 
microcalometer DASM-5M (Bureau of Biological Instrumentation, 
Pushchino, Russia), with a cell volume of 1 ml. The rate of heating was 
1 K/min and the excess pressure was kept equal to 3.6 atm. The protein 
concentration was 0.5 1.0 mg/ml. In calculations the AFP partition 
volume of 0.72 cm3/g (see [33]) was used. The excess heat capacity of 
the protein in solution was determined as described in [34]. 
All solutions contained 0.15 M NaCI and were equilibrated overnight 
against a corresponding buffer by dialysis. 
Circular dichroism spectra were obtained on a Jasko-600 spectropo- 
larimeter (Japan Spectroscopic Co., Tokyo, Japan) equipped with a 
temperature-controlled hol er. The cell pathlength was 0.15 mm. The 
protein concentration was 0.8 mg/ml. All solutions contained 0.15 M 
NaC1. Measurements were done at 23 °C. 
Fluorescence measurements were made with an Aminco (SPF- 
100CS) corrected spectrofluorimeter (American Instrument Corp.. Sil- 
ver Spring, MD). The cell pathlength was 10.0 mm. Protein and ANS 
concentrations were 0.005 mg/ml. ANS binding was registered by the 
characteristic increase in the ANS fluorescence intensity [32]. All solu- 
tions contained 0.15 M NaC1. Measurements were done at 23°C. 
Protein concentrations were determined by the absorbance at280 nm 
on a Cary spectrophotometer. The extinction coefficient was deter- 
mined according to a well-known method based on the nitrogen deter- 
I mg/ml  mination [35] and was et c,,,.2s0 = 0.365. 
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Fig. 1. Temperature dependence of partial molar heat capacity of 
human ~-fetoprotein at pH 7.2 (N) and 3.1 (MG). The solutions con- 
tained 0.15 M NaC1. 
3. Resu l t s  
3.1. The acidJorm of AFP is' denatured 
Since the AFP polypeptide chain contains only one trypto- 
phan among 600 amino acid residues, it was not a surprise that 
its circular dichroism (CD) spectra in the near ultra violet (UV) 
region are weakly pronounced and do no differ much in water 
and 9 M urea (data not shown). This was the reason for the use 
of other structural methods to find out whether AFP has a rigid 
tertiary structure at given conditions. One such approach is 
scanning microcalorimetry [29] (the presence of a heat absorp- 
tion peak on the heat capacity vs. temperature curves under the 
temperature-induced d naturation of protein molecules is usu- 
ally considered as direct evidence for the cooperative melting 
of the protein rigid tertiary structure [29]). 
Fig. 1 presents the partial molar heat capacity vs. tempera- 
ture curves for human c~-fetoprotein at pH 7.2 and 3.1. One can 
see that at pH 7.2 the curve contains the characteristic heat 
absorption peak. From the analysis of this curve with the use 
of well-known equations [29] it is possible to determine calori- 
metric (AH cal) and effective (A/P t~) enthalpy values, a compar- 
ison of which can provide information on the mechanism of the 
given temperature-induced transition [29]. In our case, the cal- 
orimetric enthalpy is practically equal to the effective one 
(A/-P ~ = 476 kJ/M, AIP tY -- 514 kJ/M; and AI-Ft/AI4 ~ -- 1.08). 
This means that temperature-induced d naturation of AFP at 
pH 7.2 can be considered as a two-state process. In other 
words, a cooperative unit coincides with a protein molecule, i.e. 
a protein molecule denatures as a whole without he coexistence 
of native and denatured parts in the same molecule. 
Another situation is observed for AFP molecules at pH 3.1. 
As follows from Fig. 1, in this case the characteristic heat 
absorption peak is absent. This means that at low pH the AFP 
molecule has no rigid tertiary structure, i.e. it is already dena- 
tured. 
The pecularities of thermodynamic studies of AFP denatura- 
tion will be described elsewhere. 
3.2. The acid form of AFP has pronounced secondary structure 
Fig. 2 shows AFP CD spectra in the far UV region in the 
native state (pH 7.2), the acid state (pH 3.1) and in 9.0 M urea. 
One can see that the CD spectrum in 9 M urea is typical of the 
completely unfolded state, while the CD spectrum at pH 3.1 is 
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Fig. 2. Far UV circular dichroism spectra of AFP in the native state 
at pH 7.2 (N), acid form at pH 3.1 (MG) and completely unfolded state 
at pH 7.2, 9 M urea (U). The solutions contained 0.15 M NaC1. All 
measurements were done at 23°C. 
comparable with that of the native state. This indicates that in 
the acid form AFP has a native-like content of secondary struc- 
ture. 
3.3. The acidJbrm of AFP is compact 
It is known that unfolding of the protein molecule is accom- 
panied by a red shift of the tryptophan (Trp) fluorescence 
maximum [30]. Fig. 3 shows Trp fluorescence spectra of human 
AFP in the native state (pH 7.2), acid form (pH 3.1) and in 9.0 
M urea. It shows that the maximum of spectrum for the acid 
form (curve 2) is only slightly shifted to the red region as 
compared with the native state (curve 1) and is far from that 
of the completely unfolded state (curve 3). This indicates that 
the Trp residue of AFP in the acid form is inaccessible to the 
solvent, which may suggest hat at least the Trp-containing 
domain of the protein molecules in this state are compact. 
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Fig. 3. Trp fluorescence spectra of AFP in different conformational 
states (see legend to Fig. 2). The solutions contained 0.15 M NaCI. All 
measurements were done at 23 °C. 
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Fig. 4. Fluorescence spectra of ANS in the presence of AFP in different 
conformational states (see the legend to Fig. 2). The solutions contained 
0.15 M NaC1. Protein and ANS concentrations were 0.005 mg/ml. All 
measurements were done at 23°C. 
3.4. The acidJorm qf AFP  binds strongly to ANS 
Fig. 4 presents the results of 8-anilinonaphthalene-l-sul- 
phonate (ANS) fluorimetric studies of AFP  in the native, com- 
pletely unfolded and acid states. It is known that the binding 
of ANS is accompanied by a strong increase in its fluorescence 
intensity and by a blue shift of the spectrum maximum [31]. Fig. 
4 shows that both native and acid forms of AFP  bind ANS, but 
the affinity of the acid form to ANS is essentially higher. It has 
been shown that in some cases ANS binds to solvent-accessible 
clusters of non-polar groups in the native state [31,32], but its 
binding to the molten globule state is much stronger [32]. 
4. Discussion 
The results presented in this paper show that the acid form 
of AFP  from human cord serum possesses all the properties of 
the molten globule state. Indeed, at pH 3.1 the AFP  molecule 
is denatured. On the other hand, it is practically as compact as 
the native one and preserves a pronounced secondary structure. 
At last, the acid form of AFP  has a larger affinity to ANS as 
compared with the native and completely unfolded states, 
which is the general sensitive test for molten globule formation 
[321. 
We suggest hat the conformational transition of the AFP  
molecule from the native to the molten globule state can play 
an important role in the functioning of this protein. It is known 
that AFP, being a transport protein, binds its ligands (e.g. 
unsaturated fatty acids) with a high association constant [2]. 
This permits it to avoid their spontaneous release in serum. On 
the other hand, near (or within) the target cells these ligands 
must leave the AFP  molecule. We assume that this process is 
connected with the transformation of a rigid native protein 
molecule into the molten globule, which results in a substantial 
increase in flexibility and facilitates the release of ligands [28]. 
It is necessary to emphasize that the native molten globule 
transition can occur in a living cell where a protein molecule 
can be strongly influenced by electrostatic fields and the or- 
ganic moiety of membranes [28]. 
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